Read More

Liquidia Corporation Announces $100M In New Financings; Agreed To $75M Sale Of Common Stock To Fund Affiliated With Patient Square Capital In A Private Placement; Additional Advance Of $25M From Healthcare Royalty Under Current Financing Agreement

Agreed to $75.0 million sale of common stock to fund affiliated with Patient Square Capital in a private placementAdditional advance of $25.0 million from HealthCare Royalty under current financing

LQDA

Read More

Latin American Cannabis Co. Blueberries Medical Wraps Up 2023 With Multi-Million Dollar Private Placement Deal

Blueberries Medical, a Latin American licensed producer of medicinal cannabis and cannabis-derived products, has announced a non-brokered private placement, to raise approximately CA$1.9m ($1.4m). The company announced the sale of 180,716,00 common shares at CA$0.011 per share. The net proceeds from the sale will be used to repay existing debt and for general corporate and working capital purposes. The offering was led by Terraflos, a Latin American company founded and controlled by Facundo Garreton, who serves as Blueberries' chairman, CEO, and director. Terraflos is exploring opportunities in Argentina, Mexico, and Brazil and plans to expand into those markets in the near future.

ALID

Read More

22nd Century Group Exits Cannabis Industry, Closes Franchise Sale Deal

22nd Century Group, a biotechnology company focused on plant genetics and cannabis research, has announced the sale of its hemp/cannabis assets. The sale, along with the assignment of a non-strategic hemp/cannabis asset in Colorado, is expected to reduce the company's debt by $3.2 million. An additional $2 million reduction will come from the buyer's payment of a secured promissory note. After these transactions, the remaining outstanding debt is expected to be approximately $8.8 million. The company's chairman and CEO, Larry Firestone, stated that the sale will help reduce operating costs and move the business towards a sustainable, cash-positive operating basis. The insurance proceeds from a fire at the company's manufacturing facility in Grass Valley will also be used to further reduce the debt.

XXII

Read More

Cannabis Co. Vext Announces Debt Conversion, Opens Door To 27 Million Shares For Investors

Vext Science has reached agreements with the holders of the company's existing secured non-convertible debentures to convert the outstanding principal amount of $4.6m, plus interest and a conversion incentive fee, into 27,700,625 common shares of the company. The conversion is subject to regulatory approval and is expected to be completed in due course. Upon completion, all existing security held by the debenture holders will be released and discharged. Sopica Special Opportunities Fund Limited, an insider shareholder of Vext Science, is a debenture holder and is expected to acquire common shares as part of the conversion transaction.

CSE:VEXT

Read More

Surf Air Mobility Enters Into Binding Terms For A $35.2M Mandatory Convertible Debenture With GEM Global Yield LLC; Parties Agree To Cancel Previously Issued Shares, Restrict Sales And Redemption Rights, Increase Capacity Under $400M Share Subscription

Parties Agree to Cancel Previously Issued Shares, Restrict Sales and Redemption Rights, and Increase Capacity Under $400 Million Share Subscription FacilitySurf Air Mobility Inc. (NYSE:SRFM) (the "Company"), the air

SRFM